Ashkan Shoamanesh

Dr. Ashkan Shoamanesh, Associate Professor of Neurology at McMaster University, joins host Dr. Negar Asdaghi to review top cerebrovascular research of the year. They discuss the timing of anticoagulation for atrial fibrillation-related stroke, ESIS mechanisms and potential treatments, the CHANCE 3 trial comparing colchicine vs placebo in stroke patients, the SCAPED NEX trial exploring the impact of COVID on neuroprotective trials, and the use of neuroenterite for stroke patients along with other notable stroke research in 2023.

Ashkan Shoamanesh discusses the ANNEXA-I Trial's impact on hematoma volume expansion in intracerebral hemorrhage patients on Factor Xa inhibitors. Topics include challenges in reversing effects, trial design, safety analyses, and clinical outcomes.